Skip to main content
Log in

Periphere neuroblastische Tumoren im Kindesalter

Peripheral neuroblastic tumors in childhood

  • Schwerpunkt: Kindliche Tumoren
  • Published:
Die Pathologie Aims and scope Submit manuscript

Zusammenfassung

Periphere neuroblastäre Tumoren sind die viertgrößte Gruppe maligner Tumoren im Kindesalter. Den weitaus größten Anteil dieser Tumoren bildet das Neuroblastom mit den Subtypen des undifferenzierten, des gering differenzierten und des differenzierenden Neuroblastoms. Außerdem gehören das Ganglioneuroblastom, ein Komposittumor aus Schwann-Zell-Stroma und Neuroblasten sowie das benigne Ganglioneurom zu den peripheren neuroblastischen Tumoren. Im Rahmen dieser Übersicht werden histopathologische Diagnosekriterien und Graduierungssysteme sowie häufige, prognostisch und therapeutisch relevante molekulare Veränderungen erläutert.

Abstract

Peripheral neuroblastic tumors represent the fourth-largest group of malignant tumors in childhood. The majority of these tumors are neuroblastomas, which can be classified into undifferentiated, poorly differentiated, and differentiating subtypes. In addition, peripheral neuroblastic tumors include ganglioneuroblastoma, a composite tumor composed of Schwannian cell stroma and neuroblasts as well as benign ganglioneuroma. In this overview, histopathological diagnostic criteria and grading systems, as well as common molecular alterations that are of prognostic and therapeutic significance, are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Ackermann S, Cartolano M, Hero B et al (2018) A mechanistic classification of clinical phenotypes in neuroblastoma. Science 362(6419):1165–1170. https://doi.org/10.1126/science.aat6768

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Alaminos M, Davalos V, Cheung N‑KV GWL, Esteller M (2004) Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J Natl Cancer Inst 96(16):1208–1219. https://doi.org/10.1093/jnci/djh224

    Article  CAS  PubMed  Google Scholar 

  3. Cheung N‑KV (2005) Neuroblastoma. Pediatric oncology. Springer, Berlin, Heidelberg, New York, S 87–94 (With 48 tables)

    Book  Google Scholar 

  4. Fetahu IS, Taschner-Mandl S (2021) Neuroblastoma and the epigenome. Cancer Metastasis Rev 40(1):173–189. https://doi.org/10.1007/s10555-020-09946-y

    Article  PubMed  PubMed Central  Google Scholar 

  5. Gesellschaft für Pädriatische Onkologie und Hämatologie (2002) Neuroblastomstudie NB97. Studienprotokoll

    Google Scholar 

  6. Janoueix-Lerosey I, Schleiermacher G, Delattre O (2010) Molecular pathogenesis of peripheral neuroblastic tumors. Oncogene 29(11):1566–1579. https://doi.org/10.1038/onc.2009.518

    Article  CAS  PubMed  Google Scholar 

  7. Jansky S, Sharma AK, Körber V, Quintero A, Toprak UH, Wecht EM, Gartlgruber M, Greco A, Chomsky E, Grünewald TGP, Henrich K‑O, Tanay A, Herrmann C, Höfer T, Westermann F (2021) Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma. Nat Genet 53(5):683–693. https://doi.org/10.1038/s41588-021-00806-1

    Article  CAS  PubMed  Google Scholar 

  8. Koelsche C, von Deimling A (2022) Methylation classifiers: Brain tumors, sarcomas, and what’s next. Genes Chromosomes Cancer 61(6):346–355. https://doi.org/10.1002/gcc.23041

    Article  CAS  PubMed  Google Scholar 

  9. Peuchmaur M, d’Amore ESG, Joshi VV, Hata J, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK, Shimada H (2003) Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 98(10):2274–2281. https://doi.org/10.1002/cncr.11773

    Article  PubMed  Google Scholar 

  10. Pickles JC, Stone TJ, Jacques TS (2020) Methylation-based algorithms for diagnosis: experience from neuro-oncology. J Pathol 250(5):510–517. https://doi.org/10.1002/path.5397

    Article  PubMed  Google Scholar 

  11. RKI (2021) Krebs in Deutschland für 2017/2018

    Google Scholar 

  12. Sarnacki S, Pio L (2020) Neuroblastoma. Springer, Cham, S 57–66

    Book  Google Scholar 

  13. Shimada H, Ikegaki N (2019) Neuroblastoma pathology and classification for precision prognosis and therapy stratification, S 1–22

    Google Scholar 

  14. Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73(2):405–416. https://doi.org/10.1093/jnci/73.2.405

    Article  CAS  PubMed  Google Scholar 

  15. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B (1999) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86(2):349–363

    Article  CAS  PubMed  Google Scholar 

  16. Simon T (2019) S1 Leitlinie Neuroblastom. AWMF-Register-Nr.: 025/008

    Google Scholar 

  17. Theissen J, Boensch M, Spitz R, Betts D, Stegmaier S, Christiansen H, Niggli F, Schilling F, Schwab M, Simon T, Westermann F, Berthold F, Hero B (2009) Heterogeneity of the MYCN oncogene in neuroblastoma. Clin Cancer Res 15(6):2085–2090. https://doi.org/10.1158/1078-0432.CCR-08-1648

    Article  CAS  PubMed  Google Scholar 

  18. Tornóczky T, Semjén D, Shimada H, Ambros IM (2007) Pathology of peripheral neuroblastic tumors: significance of prominent nucleoli in undifferentiated/poorly differentiated neuroblastoma. Pathol Oncol Res 13(4):269–275. https://doi.org/10.1007/BF02940304

    Article  PubMed  Google Scholar 

  19. Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson ADJ, Cohn SL, DuBois SG (2014) Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol 32(28):3169–3176. https://doi.org/10.1200/JCO.2014.56.1621

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wei M, Ye M, Dong K, Dong R (2020) Mass screening for neuroblastoma in infants. Discov Med 30(160):63–70

    PubMed  Google Scholar 

  21. Westermann F, Schwab M (2002) Genetic parameters of neuroblastomas. Cancer Lett 184(2):127–147. https://doi.org/10.1016/s0304-3835(02)00199-4

    Article  CAS  PubMed  Google Scholar 

  22. WHO Classification of Tumours Editorial Board (2022) Paediatric tumours. WHO, Lyon

    Google Scholar 

  23. Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, Foster J, Zhou J, Zhang R (2021) Molecular targeting therapies for neuroblastoma: progress and challenges. Med Res Rev 41(2):961–1021. https://doi.org/10.1002/med.21750

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marit Bernhardt.

Ethics declarations

Interessenkonflikt

M. Bernhardt und C. Vokuhl geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Schwerpunktherausgeber

Christian Vokuhl, Bonn

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bernhardt, M., Vokuhl, C. Periphere neuroblastische Tumoren im Kindesalter. Pathologie 44, 366–372 (2023). https://doi.org/10.1007/s00292-023-01227-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-023-01227-z

Schlüsselwörter

Keywords

Navigation